Pandite Arundathy N. 4
4 · Shattuck Labs, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Shattuck Labs (STTK) CMO Pandite Arundathy Sells 30,000 Shares
What Happened
- Pandite Arundathy, Chief Medical Officer of Shattuck Labs (STTK), sold 30,000 shares on June 30, 2026. The reported weighted-average price was $7.01 per share, for gross proceeds of approximately $210,300. The Form 4 lists the transaction as an open-market or private sale (code S).
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely).
- Price: weighted average $7.01; individual trades ranged from $6.62 to $7.40 (footnote).
- Shares sold: 30,000; gross proceeds ≈ $210,300.
- Footnote F1: Sale executed pursuant to a Rule 10b5-1 trading plan adopted February 2, 2026.
- Footnote F2: Weighted average price reported; the filer can provide the number of shares sold at each price on request.
- Shares owned after transaction: not specified in the provided excerpt of the filing.
Context
- This was a sale (disposition) executed under a pre-established 10b5-1 plan, which is commonly used to schedule sales in advance and is generally considered routine; the filing itself does not state the seller’s motivation.
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-06-30$7.01/sh−30,000$210,300→ 136,219 total
Footnotes (2)
- [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026.
- [F2]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.62 to $7.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Signature
/s/ Andrew R. Neill, Attorney-in-fact for Arundathy N. Pandite|2026-07-02